Home Infusion Therapy Devices Market By device Type (Infusion Pump, Needleless Connectors, Intravenous Set, Others), By Pump Type (Enteral Infusion Pump, Insulin Infusion Pump, Syringe Infusion Pump, Patient-Controlled Analgesia, Volumetric Infusion Pump, Others), By Application (Infectious Diseases, Pain Management, Enteral Nutrition, Chemotherapy, Total Parenteral Nutrition, Others), By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Home Infusion Therapy Devices Market size was valued at USD 23.3 billion in 2021 and is expected to reach a value USD 53.7 billion by 2028, at a CAGR of 11% during the forecast period 2022-2028. Infusion therapy has become a common technique of pain relief, particularly for conditions when oral medicine is ineffective. The medication is frequently given intravenously or subcutaneously in this method. Patients are converting from traditional therapies to specialised infusion therapy treatments as a result of technological advancements. Home infusion therapy devices are used to administer drug solutions to treat various diseases that are unresponsive to the oral medication such as gastrointestinal diseases, cancer, and pain. Home infusion therapy declines the unplanned hospitalization and also improves the medication adherence. Most commonly used home infusion therapy devices for drug administration include intravenous set, needleless connectors, and infusion pumps among others. Due to increase in the prevalence of chronic diseases majorly diabetes and cancer and increase in awareness are anticipated to fuel the home infusion therapy devices market over the forecast period. Moreover, technological advancements such as the introduction of smart pumps that enhancing the overall ease of using home infusion devices are expected to drive market revenue. Furthermore, acquisitions and mergers, collaborations, and product launchings are the key strategies followed by the market players for generating larger revenue in the home infusion therapy devices market. For instance, in March 2016, PromptCare acquired Boston Home Infusion for expanding the product portfolio in Boston area. Similarly, in October 2016, ICU Medical Inc. acquired Hospira Infusion Systems for strengthening its home infusion therapy devices portfolio. Key Developments: In April 2017, Becton, Dickinson and company acquired Caesarea Medical Electronics for strengthening infusion system portfolio including home infusion therapy devices

Home Infusion Therapy Devices Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Home Infusion Therapy Devices Market Dynamics

Increase in the demand for home infusion therapy from patients, high cost for hospitalization treatment, a wide range of applications with infusion devices, and presence of unmet medical needs are anticipated to fuel the home infusion therapy devices market over the forecast period. Moreover, increase in geriatric population, technological developments in home infusion therapy devices, and high prevalence of chronic diseases like diabetes and cancer are expected to boost the home infusion therapy devices market over the forecast period. However, the risk associated with the drug administration, product recalls, unfavorable reimbursement policies and misguidance about the usage of the device are impede the growth of home infusion therapy devices market over the forecast years.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Home Infusion Therapy Devices Market Segmentation

By Device
  • Infusion Pumps
  • Needleless Connectors
  • Intravenous Sets
  • Others
Pump Type
  • Enteral Infusion Pumps
  • Insulin Infusion Pumps
  • Syringe Infusion Pumps
  • Patient-Controlled Analgesia
  • Volumetric Infusion Pumps
  • Others
By Application
  • Infectious Diseases
  • Pain Management
  • Nutrition
  • Chemotherapy
  • Others
Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Frequently Asked Questions

The home infusion therapy devices market is projected to expand at a CAGR of 11% during the forecast period

Fresenius Kabi AG, Braun Melsungen AG, ICU Medical, Inc, Terumo Corporation, JMS Co. Ltd.

North America is the fastest-growing region for home infusion therapy devices market

[urltag url='request-table-of-content']

  • Fresenius Kabi AG (Germany)
  • Braun Melsungen AG (Germany)
  • ICU Medical, Inc. (U.S.)
  • Terumo Corporation (Japan)
  • JMS Co. Ltd. (Japan)
  • Smiths Medical (U.S.)
  • Baxter International Inc. (U.S.)
  • Caesarea Medical Electronics Ltd. (Becton, Dickinson and Company) (U.S.)
  • Hoffmann-La Roche Ltd. (Switzerland)